After several years in which the biggest U.S. drugstore chains shrank their store counts, CVS is planning to open roughly 60 new locations in 2026. Against a backdrop of thousands of retail closures, a few dozen openings is a small number, but the direction is what makes it notable. For older shoppers who depend on a nearby pharmacy counter to fill prescriptions and receive vaccines, a chain that is adding stores rather than only closing them is a modest signal that the years-long retreat in drugstore access may be starting to level off.
What CVS is actually doing
The roughly 60 openings represent a deliberate expansion, not a return to aggressive growth. As TheStreet reported in its coverage of the drugstore sector, CVS intends to add the new locations in 2026 even as the industry overall continues to close far more stores than it opens. The company frames the move through its own communications, and its CVS Health newsroom is where the chain lays out its store strategy for anyone tracking where the openings land.
The context is a period of heavy retrenchment. CVS and its rivals spent recent years announcing large-scale closures, thinning out overlapping locations, exiting underperforming markets, and responding to prescription-reimbursement pressure and shifting shopping habits. Set against that history, a plan to open dozens of stores is a change in posture, a company that had been subtracting locations choosing to add some back.
It would be a mistake to read the number as a reversal of the broader trend. Sixty openings is dwarfed by the pace of closures across retail, and even within the drugstore category the net direction remains one of contraction. What the figure marks is a possible inflection, the first sign that the sharpest phase of the pullback may be behind the industry, rather than proof that pharmacies are expanding again.
Free retirement updates: A quiet rule change can shrink your Social Security or Medicare check, and no one warns you. The free Retirement Shield newsletter catches these early and tells you what to do. Get it free.
Why a new pharmacy counter matters to a fixed budget
For a household managing several prescriptions, the location of the nearest pharmacy is a recurring cost, not a one-time convenience. A counter within easy reach means shorter trips, lower transportation spending, and in-person access to a pharmacist who can catch a harmful drug interaction or administer a Medicare-covered vaccine. When a chain opens a store in an area that lost one, it can restore access that had turned into a longer, more expensive errand.
Where CVS chooses to open is therefore as important as how many stores it adds. New locations placed in areas already saturated with pharmacies do little for access, while openings in communities that recently lost their nearest counter can meaningfully reduce the burden on residents who no longer drive. The 60-store figure alone does not reveal which of those it will be, which is why the strategy behind the openings matters more than the headline count.
The improvement, where it happens, tends to be quiet. A patient who can once again fill a monthly prescription close to home is less likely to stretch doses, delay a refill, or skip a shot, the small compromises that a longer trip encourages and that can lead to larger medical bills later. A restored pharmacy counter does not announce itself as a financial benefit, but for the people it serves, it removes a steady drag on both time and money.
How much to read into the counter-trend
Industry-wide data still points down. Coresight Research continues to track a record pace of retail closures across the sector, and drugstores remain a significant part of that total, so any single chain’s openings sit inside a larger picture of contraction. A saver or patient watching the trend should weigh the 60 openings against the far larger number of counters going dark, rather than treat them as evidence the shakeout is over.
What a modest expansion does suggest is that the biggest operators may be finding the floor, closing the least profitable stores while selectively investing where the economics work. That is a healthier pattern than indiscriminate shrinkage, because it implies the surviving footprint is being shaped around demand rather than simply cut. Whether it holds depends on prescription economics and consumer habits that remain in flux.
For an older resident, the useful takeaway is narrower than the sector headlines. The question is not whether the drugstore industry is growing again, it is not, but whether access in a specific community is stabilizing. CVS adding stores is one data point that, in the right places, it might be. The value of that depends entirely on whether one of those roughly 60 doors opens near enough to matter.
This article was researched and drafted with the assistance of AI and reviewed by The Money Overview editorial team.
More Financial Reading
